bexarotene
2001-391G
Phase 2 small_molecule completed
Quick answer
bexarotene for Cutaneous T-Cell Lymphoma is a Phase 2 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Cutaneous T-Cell Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed